Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3)

References

• FerrariAJCharlsonFJNormanREBurden of depressive disorders by country, sex, age, and year: findings from the Global Burden of Disease Study 2010PLoS Med20131011e100154724223526
   PubMed Web of Science ®Google Scholar
• KnothRLBolgeSCKimETranQVEffect of inadequate response to treatment in patients with depressionAm J Manag Care2010168e188e19620690785
   PubMed Web of Science ®Google Scholar
• Machado-VieiraRHenterIDZarateCAJrNew targets for rapid antidepressant actionProg Neurobiol2017152213726724279
   PubMed Web of Science ®Google Scholar
• OtteCGoldSMPenninxBWMajor depressive disorderNat Rev Dis Primers201621606527629598
   PubMed Web of Science ®Google Scholar
• BauerMBschorTPfennigAWorld Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary careWorld J Biol Psychiatry2007826710417455102
   PubMed Web of Science ®Google Scholar
• RushAJTrivediMHWisniewskiSRAcute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D reportAm J Psychiatry2006163111905191717074942
   PubMed Web of Science ®Google Scholar
• BlierPAtypical antipsychotics for mood and anxiety disorders: safe and effective adjuncts?J Psychiatry Neurosci200530423223316049565
   PubMed Web of Science ®Google Scholar
• SerafiniGPompiliMBelvederi MurriMThe effects of repetitive transcranial magnetic stimulation on cognitive performance in treatment-resistant depression. A systematic reviewNeuropsychobiology201571312513925925699
   PubMed Web of Science ®Google Scholar
• CusinCDoughertyDDSomatic therapies for treatment-resistant depression: ECT, TMS, VNS, DBSBiol Mood Anxiety Disord2012211422901565
   PubMedGoogle Scholar
• BerlimMTvan den EyndeFDaskalakisZJEfficacy and acceptability of high frequency repetitive transcranial magnetic stimulation (rTMS) versus electroconvulsive therapy (ECT) for major depression: a systematic review and meta-analysis of randomized trialsDepress Anxiety201330761462323349112
   PubMed Web of Science ®Google Scholar
• BerrocosoESánchez-BlázquezPGarzónJMicoJAOpiates as antidepressantsCurr Pharm Des200915141612162219442177
   PubMed Web of Science ®Google Scholar
• LutzP-EKiefferBLOpioid receptors: distinct roles in mood disordersTrends Neurosci201336319520623219016
   PubMed Web of Science ®Google Scholar
• WilliamsNRHeifetsBDBlaseyCAttenuation of antidepressant effects of ketamine by opioid receptor antagonismAm J Psychiatry Epub2018829
   Web of Science ®Google Scholar
• BérubéPLaforestSBhatnagarSDroletGEnkephalin and dynorphin mRNA expression are associated with resilience or vulnerability to chronic social defeat stressPhysiol Behav201312223724523665402
   PubMed Web of Science ®Google Scholar
• HsuDTSanfordBJMeyersKKIt still hurts: altered endogenous opioid activity in the brain during social rejection and acceptance in major depressive disorderMol Psychiatry201520219320025600108
   PubMed Web of Science ®Google Scholar
• NummenmaaLKarjalainenTOpioidergic regulation of pain and Pleasure in human social relationshipsNeuropsychopharmacology201843121721829192663
   PubMed Web of Science ®Google Scholar
• KennedySEKoeppeRAYoungEAZubietaJKDysregulation of endogenous opioid emotion regulation circuitry in major depression in womenArch Gen Psychiatry200663111199120817088500
   PubMed Web of Science ®Google Scholar
• KnollATCarlezonWADynorphin, stress, and depressionBrain Res20101314567319782055
   PubMed Web of Science ®Google Scholar
• RibeiroSCKennedySESmithYRStohlerCSZubietaJKInterface of physical and emotional stress regulation through the endogenous opioid system and mu-opioid receptorsProg Neuropsychopharmacol Biol Psychiatry20052981264128016256255
   PubMed Web of Science ®Google Scholar
• TenorePLPsychotherapeutic benefits of opioid agonist therapyJ Addict Dis20082734965
   PubMed Web of Science ®Google Scholar
• BodkinJAZornbergGLLukasSEColeJOBuprenorphine treatment of refractory depressionJ Clin Psychopharmacol199515149577714228
   PubMed Web of Science ®Google Scholar
• EhrichETurncliffRDuYEvaluation of opioid modulation in major depressive disorderNeuropsychopharmacology20154061448145525518754
   PubMed Web of Science ®Google Scholar
• KarpJFButtersMABegleyAESafety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adultsJ Clin Psychiatry2014758e785e79325191915
   PubMed Web of Science ®Google Scholar
• SerafiniGAdavastroGCanepaGThe efficacy of buprenorphine in major depression, treatment-resistant depression and suicidal behavior: a systematic reviewInt J Mol Sci20181982410
   PubMed Web of Science ®Google Scholar
• EmrichHMVogtPHerzAKisslingWAntidepressant effects of buprenorphineLancet19823208300709
   Google Scholar
• NyhuisPWGastparMScherbaumNOpiate treatment in depression refractory to antidepressants and electroconvulsive therapyJ Clin Psychopharmacol200828559359518794671
   PubMed Web of Science ®Google Scholar
• YovellYBarGMashiahMUltra-low-dose buprenorphine as a time-limited treatment for severe suicidal ideation: a randomized controlled trialAm J Psychiatry2016173549149826684923
   PubMed Web of Science ®Google Scholar
• BidlackJMKnappBIDeaverDRPlotnikavaMArnelleDQuinnAMALKS 5461: affinity, potency, and functional activity of buprenorphine and samidorphan alone and in combinationPresented at: 73rd Annual Meeting of the Society of Biological PsychiatryMay 10–12, 2018New York, NY
   Google Scholar
• FavaMMemisogluAThaseMEOpioid modulation with buprenorphine/samidorphan as adjunctive treatment for inadequate response to antidepressants: a randomized double-blind placebo-controlled trialAm J Psychiatry2016173549950826869247
   PubMed Web of Science ®Google Scholar
• FavaMThaseMTrivediMALKS 5461 (a buprenorphine-samidorphan combination) for adjunctive treatment of major depressive disorder: results from analyses of US patients from three independent placebo-controlled trialsNeuropsychopharmacology2017422
   Web of Science ®Google Scholar
• FavaMEvinsAEDorerDJSchoenfeldDAThe problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approachPsychother Psychosom200372311512712707478
   PubMed Web of Science ®Google Scholar
• CiprianiAFurukawaTASalantiGComparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysisLancet2018391101281357136629477251
   PubMed Web of Science ®Google Scholar
• FurukawaTACiprianiAAtkinsonLZPlacebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studiesLancet Psychiatry20163111059106627726982
   PubMed Web of Science ®Google Scholar
• UndurragaJBaldessariniRJRandomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic reviewNeuropsychopharmacology201237485186422169941
   PubMed Web of Science ®Google Scholar
• KhinNAChenY-FYangYYangPLaughrenTPExploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applicationsJ Clin Psychiatry201172446447221527123
   PubMed Web of Science ®Google Scholar
• KhanASchwartzKStudy designs and outcomes in antidepressant clinical trialsEssent Psychopharmacol20056422122616041918
   PubMedGoogle Scholar
• FariesDEHeiligensteinJHTollefsonGDPotterWZThe double-blind variable placebo lead-in period: results from two antidepressant clinical trialsJ Clin Psychopharmacol200121656156811763002
   PubMed Web of Science ®Google Scholar
• TrivediMHRushHDoes a placebo run-in or a placebo treatment cell affect the efficacy of antidepressant medications?Neuropsychopharmacology199411133437945742
   PubMed Web of Science ®Google Scholar
• FavaMThaseMETrivediMHOpioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: two randomized controlled studiesMol Psychiatry Epub20181029
   Web of Science ®Google Scholar
• FavaMFreemanMPFlynnMDouble-blind, proof-of-concept (POC) trial of low-field magnetic stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD)Brain Stimul2018111758429030111
   PubMed Web of Science ®Google Scholar
• FavaMMischoulonDIosifescuDA double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A study)Psychother Psychosom2012812879722286203
   PubMed Web of Science ®Google Scholar
• PapakostasGISheltonRCZajeckaJML-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trialsAm J Psychiatry2012169121267127423212058
   PubMed Web of Science ®Google Scholar